FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1201828006: Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4945165016 Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4945166015 Gliclazide 60 mg and metformin hydrochloride 500 mg prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) est un(e) (attribut) Gliclazide and metformin only product in oral dose form true Inferred relationship Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) a une forme pharmaceutique (attribut) Prolonged-release oral tablet true Inferred relationship Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) Metformin hydrochloride true Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has precise active ingredient Gliclazide (substance) true Inferred relationship Some 2
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has basis of strength substance (attribute) Gliclazide (substance) true Inferred relationship Some 2
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 2
Product containing precisely gliclazide 60 milligram and metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start